Showing results (1361-1370 of 2,286) with videos related to

Sort By:
Pageof 229
HIV Medicine|April 25, 2006
Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV-infected patients started on a protease inhibitor-containing regimenV Le Moing, C Rabaud, V Journot, et al.
HIV Medicine|August 15, 2006
The value of serum albumin in pretreatment assessment and monitoring of therapy in HIV/AIDS patientsH O Olawumi, P O Olatunji
HIV Medicine|August 15, 2006
Influence of a monocyte chemoattractant protein 1 mutated allele on the response to protease inhibitor-based antiretroviral therapyB Coll, C Alonso-Villaverde, S Parra, et al.
HIV Medicine|August 15, 2006
The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern AlbertaS Gingues, M J Gill
HIV Medicine|August 15, 2006
Incidence and risk factors of rash associated with efavirenz in HIV-infected patients with preceding nevirapine-associated rashW Manosuthi, S Thongyen, N Chumpathat, et al.
HIV Medicine|August 15, 2006
Abnormal glucose metabolism among older men with or at risk of HIV infectionA A Howard, M Floris-Moore, Y Lo, et al.
HIV Medicine|September 2, 2006
A prospective evaluation of the effect of atazanavir on the QTc interval and QTc dispersion in HIV-positive patientsA J Busti, J P Tsikouris, M J Peeters, et al.
HIV Medicine|September 2, 2006
Counteracting muscle wasting in HIV-infected individualsW D Dudgeon, K D Phillips, J A Carson, et al.
HIV Medicine|September 2, 2006
Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant womenM C Marazzi, P Germano, G Liotta, et al.
HIV Medicine|November 16, 2006
Efavirenz and chronic neuropsychiatric symptoms: a cross-sectional case control studyT A Rihs, K Begley, D E Smith, et al.
Pageof 229